When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
BAYRY - FDA rejects Blueprint Medicines' avapritinib in fourth-line GIST
Bayer AG ADR
Blueprint Medicines (NASDAQ:BPMC) reports that it has received a Complete Response Letter (CRL) from the FDA regarding its marketing application for avapritinib in fourth-line gastrointestinal tumor (GIST).
More news on: Blueprint Medicines Corporation, Bayer Aktiengesellschaft, Deciphera Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move,